Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years …

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

This article describes the pharmacology of approved parenteral anticoagulants. These
include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight …

Objectives: In a large US sample, this study measured the presentation features, testing,
treatment strategies, and outcomes of patients diagnosed with pulmonary embolism (PE) in …

Pulmonary embolism should be suspected in all patients who present with new or
worsening dyspnea, chest pain, or sustained hypotension without a clear alternative cause …

Objectives To evaluate the performance of an AI-powered algorithm for the automatic
detection of pulmonary embolism (PE) on chest computed tomography pulmonary …

Background Pulmonary embolism (PE) remains a significant cause of hospital admission
and health-care costs. Estimates of PE incidence came from the 1990s, and data are limited …

Treatment strategies for complex patients with pulmonary embolism (PE) are often debated
given patient heterogeneity, multitude of available treatment modalities, and lack of …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan
manifestations, including pleuropulmonary involvement (20–90%). The precise mechanism …

Objectives To evaluate and compare the diagnostic performances of a commercialized
artificial intelligence (AI) algorithm for diagnosing pulmonary embolism (PE) on CT …